STK38激酶通过MerTK激活促进由瘤性Ras诱导的细胞迁移
Satoshi Ohta1, Kenji Tago2, Katsumi Kasashima1
1Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
International journal of molecular sciences
|November 13, 2025
概括
瘤性Ras通过上调受体氨酸激酶MerTK的调节来促进癌细胞迁移. 这项研究确定STK38是该途径中的关键激酶,为Ras突变癌症提供了新的治疗点.
科学领域:
- 分子瘤学分子瘤学
- 细胞信号通路是细胞信号通路.
背景情况:
- 拉斯基因突变在各种癌症中很常见,但有效的治疗方法仍然有限.
- 瘤性Ras信号通过下游效应器驱动癌症的进展,需要识别新的治疗点.
研究的目的:
- 为了确定参与癌细胞迁移的瘤性Ras信号传递的新型下游效应因子.
- 阐明氨酸/氨酸激酶STK38在Ras诱导的细胞迁移中的作用.
主要方法:
- 从Ras转换的NIH-3T3细胞中净化MerTK复合体.
- 质谱分析以确定MerTK的有约束力的合作伙伴.
- 对MerTK和STK38进行淘汰研究,以评估它们对细胞迁移和信号通路的影响.
- 对激酶活性和下游效应因子激活的评估 (Rac1,Cdc42).
主要成果:
- STK38被确定为Ras转化细胞中的MerTK结合伙伴.
- 抑制STK38或MerTK显著减弱的H-Ras (G12V) 诱导的NIH-3T3细胞迁移.
- STK38激酶活性对于Ras诱导的细胞迁移和MerTK酸化至关重要.
- STK38和MerTK参与Rac1和Cdc42的激活.
结论:
- STK38在瘤性Ras诱导的细胞迁移中发挥着关键作用,作用于Ras的下游并与MerTK相互作用.
- MerTK-STK38轴代表了Ras突变癌症的潜在治疗标.
相关概念视频
01:07MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:24Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
01:26Receptor Tyrosine Kinases
17.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.8K